Tambagel, Jenny Grace .

HRN: 20-23-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2022
AMPICILLIN 1GM (VIAL)
05/19/2022
05/19/2022
IVT
2g
IVT Now
PROM X 44 Hours
Waiting Final Action 
05/19/2022
AMPICILLIN 1GM (VIAL)
05/19/2022
05/25/2022
IVT
1g
Q6
PROM X 44 Hours
Waiting Final Action 
05/19/2022
CEFUROXIME 500MG (TAB)
05/19/2022
05/26/2022
ORAL
500mg
BID
G1P1 PROM X 46h
Waiting Final Action 
05/19/2022
CEFUROXIME 750MG (VIAL)
05/19/2022
05/22/2022
IV
750mg
Q8
G1P1 PROM 46h
05/19/2022
CEFUROXIME 1.5GM (VIAL)
05/19/2022
05/19/2022
IV
1.5g
Loading Dose
G1P1 PROM 46h
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: